UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The 24‐h frequency‐volume chart in adults reporting no voiding complaints: defining reference values and analysing variables

BJU international, 2004-06, Vol.93 (9), p.1257-1261

2004

Volltextzugriff (PDF)

LASER THERAPY FOR CARCINOMA IN SITU OF THE PENIS

The Journal of urology, 2001-11, Vol.166 (5), p.1670-1671

2001

Volltextzugriff (PDF)

Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective

Annals of oncology, 2009-03, Vol.20 (3), p.403-412

2009

Volltextzugriff (PDF)

Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems

Journal of clinical pathology, 2002-12, Vol.55 (12), p.900-905

2002

Volltextzugriff (PDF)

Advanced Prostate Cancer: Immediate or Deferred Hormone Therapy?

European urology, 2001-01, Vol.39 (Suppl 1), p.15-21

Newling, D.

2001

Volltextzugriff (PDF)

Quality control of radical prostatectomy: a feasibility study

European journal of cancer (1990), 2001-05, Vol.37 (7), p.884-891

2001

Volltextzugriff (PDF)

The Use of Valrubicin for the Chemoresection of Superficial Bladder Cancer – A Marker Lesion Study

European urology, 2001-06, Vol.39 (6), p.643-647

2001

Volltextzugriff (PDF)

Orchiectomy versus goserelin and flutamide in the treatment of newly diagnosed metastatic prostate cancer. Analysis of the criteria of evaluation used in the european organization for research and treatment of cancer–‐genitourinary group study 30853

Cancer, 1993-12, Vol.72 (S12), p.3793-3798

1993

Volltextzugriff (PDF)

Introduction and background

Prostate cancer and prostatic diseases, 2002-09, Vol.5 (S2), p.S1-S2

Newling, D

2002

Volltextzugriff (PDF)

Maximal Androgen Blockade: Final Analysis of EORTC Phase III Trial 30853

European urology, 1998-02, Vol.33 (2), p.144-151

1998

Volltextzugriff (PDF)

Next steps for the PROstart initiative

Prostate cancer and prostatic diseases, 2002-01, Vol.5 (S2), p.S15-S16

Newling, D

2002

Volltextzugriff (PDF)

Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853)

Urology (Ridgewood, N.J.), 1993-08, Vol.42 (2), p.119-130

1993

Volltextzugriff (PDF)

Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies

European urology, 2002-05, Vol.41 (5), p.523-531

2002

Volltextzugriff (PDF)

Chronic cystitis caused by Corynebacterium urealyticum detected by polymerase chain reaction

European journal of clinical microbiology & infectious diseases, 2000-12, Vol.19 (12), p.949-952

2000

Volltextzugriff (PDF)

PIN I–III: When Should We Interfere?

European urology, 1999, Vol.35 (5-6), p.504-507

Newling, Don

1999

Volltextzugriff (PDF)

PROTOTHECOSIS OF THE URINARY TRACT

The Journal of urology, 2002, Vol.167 (1), p.252-252

2002

Volltextzugriff (PDF)

Don't dismiss the floating kidney

The Lancet (British edition), 2001-03, Vol.357 (9260), p.959-960

Newling, DWW

2001

Volltextzugriff (PDF)

Sarcomatoid carcinoma of the urinary bladder. Clinicopathologic analysis of 18 cases with immunohistochemical and electron microscopic findings

The American journal of surgical pathology, 1994-03, Vol.18 (3), p.241-249

1994

Volltextzugriff (PDF)

The Management of Hormone Refractory Prostate Cancer

European urology, 1996, Vol.29 (Suppl 2), p.69-74

Newling, D.W.W.

1996

Volltextzugriff (PDF)

The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group Phase III clinical trial (Protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate

European urology, 1995, Vol.28 (4), p.273-283

1995

Volltextzugriff (PDF)

Is Prostate-Specific Antigen a Valid Surrogate End Point for Survival in Hormonally Treated Patients With Metastatic Prostate Cancer? Joint Research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca Pharmaceuticals

Journal of clinical oncology, 2005-09, Vol.23 (25), p.6139-6148

2005

Volltextzugriff (PDF)

Nerve growth factor stimulates in vitro invasive capacity of DU145 human prostatic cancer cells

Journal of cancer research and clinical oncology, 1997-02, Vol.123 (2), p.107-112

1997

Volltextzugriff (PDF)

Intravesical therapy in the management of superficial transitional cell carcinoma of the bladder: the experience of the EORTC GU Group

British journal of cancer, 1990-04, Vol.61 (4), p.497-499

NEWLING, D

1990

Volltextzugriff (PDF)

Second-line treatment of metastatic prostatic carcinoma

Urolithiasis, 1997-03, Vol.25 Suppl 2 (S2), p.S73-S78

Newling, D W

1997

Volltextzugriff (PDF)

Defining an international research agenda for quality of life in men with prostate cancer

The Prostate, 1999-09, Vol.41 (1), p.58-67

1999

Volltextzugriff (PDF)

1 – 25 von 272

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(236)
Mit Volltextzugriff
(156)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The 24‐h frequency‐volume chart in adults reporting no voiding complaints: defining reference values and analysing variables

LASER THERAPY FOR CARCINOMA IN SITU OF THE PENIS

Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective

Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems

Advanced Prostate Cancer: Immediate or Deferred Hormone Therapy?

Quality control of radical prostatectomy: a feasibility study

The Use of Valrubicin for the Chemoresection of Superficial Bladder Cancer – A Marker Lesion Study

Orchiectomy versus goserelin and flutamide in the treatment of newly diagnosed metastatic prostate cancer. Analysis of the criteria of evaluation used in the european organization for research and treatment of cancer–‐genitourinary group study 30853

Introduction and background

Maximal Androgen Blockade: Final Analysis of EORTC Phase III Trial 30853

Next steps for the PROstart initiative

Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853)

Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies

Chronic cystitis caused by Corynebacterium urealyticum detected by polymerase chain reaction

PIN I–III: When Should We Interfere?

PROTOTHECOSIS OF THE URINARY TRACT

Don't dismiss the floating kidney

Sarcomatoid carcinoma of the urinary bladder. Clinicopathologic analysis of 18 cases with immunohistochemical and electron microscopic findings

The Management of Hormone Refractory Prostate Cancer

The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group Phase III clinical trial (Protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate

Is Prostate-Specific Antigen a Valid Surrogate End Point for Survival in Hormonally Treated Patients With Metastatic Prostate Cancer? Joint Research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca Pharmaceuticals

Nerve growth factor stimulates in vitro invasive capacity of DU145 human prostatic cancer cells

Intravesical therapy in the management of superficial transitional cell carcinoma of the bladder: the experience of the EORTC GU Group

Second-line treatment of metastatic prostatic carcinoma

Defining an international research agenda for quality of life in men with prostate cancer

Suchergebnisse filtern